TP53 and colorectal carcinoma: TP53 non-GOF variants were associated with poorer prognosis in right-sided CC versus left-sided CRC, while TP53 GOF versus non-GOF variants were associated with poorer prognosis in left-sided CRC, but not in right-sided CC.